RESUMO
Thirty hospitalized patients (22 men and eight women), aged between 15 and 41 years (mean = 25.4 years), with severe proven typhoid sepsis were treated with pefloxacin at daily dose of 1200 mg, divided in three doses, intravenously for the first five days and orally for the following ten days of treatment. All patients completely recovered from infection and pathogens were eradicated after 30 days of follow-up. In none of the patients was a relapse registered during the follow-up or enteric carrier state after disease. Pefloxacin therapy was well tolerated by all patients: in five patients a mild and transient epigastric pain and in one patient a mild and transient nausea were registered. Pefloxacin is a safe and effective agent for therapy of typhoid fever.
Assuntos
Pefloxacina/uso terapêutico , Febre Tifoide/tratamento farmacológico , Administração Oral , Adolescente , Adulto , Portador Sadio/tratamento farmacológico , Feminino , Humanos , Infusões Intravenosas , Masculino , Pefloxacina/administração & dosagemRESUMO
Thirteen hospitalized patients with various infections, five with typhoid fever, two with gastroenteritis, four with respiratory tract infection and two with biliary tract infection, were treated with ofloxacin at a daily dosage ranging between 600 and 900 mg orally. 12 patients completely recovered from the infection, and the pathogens were eradicated. Treatment failed in one patient suffering from respiratory tract infection. No side effects were recorded. In these cases ofloxacin can be considered as a safe and effective antimicrobial agent.
